StockNews.AI
CNC
StockNews.AI
23 days

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Centene Corporation of Class Action Lawsuit and Upcoming Deadlines - CNC

1. Centene faces a class action lawsuit for alleged securities fraud. 2. A significant stock price drop of 40.37% occurred after earnings guidance withdrawal. 3. The lawsuit relates to unlawful business practices by Centene's officers and directors. 4. Investors can become a Lead Plaintiff by contacting Pomerantz LLP by September 2025. 5. Centene cited unmet growth expectations and health risks in 22 states.

5m saved
Insight
Article

FAQ

Why Very Bearish?

The class action lawsuit and significant drop in stock price indicate investor mistrust. Historical instances, such as those involving other health care companies, show prolonged negative impacts on stock value from legal issues.

How important is it?

The class action lawsuit and significant market reaction are critical for investors’ decisions regarding Centene. Issues affecting governance and trust can severely influence stock valuation.

Why Long Term?

Legal proceedings can last years, affecting investor sentiment and stock performance. Previous cases have shown that resolutions to lawsuits can prolong uncertainty, influencing long-term stock trajectories adversely.

Related Companies

UNHCVSHUM
, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation ("Centene" or the "Company")(NYSE: CNC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Centene and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. You have until September 8, 2025, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Centene securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.         [Click here for information about joining the class action] On July 1, 2025, Centene announced that it "is withdrawing its previous 2025 GAAP and adjusted diluted earnings per share (EPS) guidance, including the underlying guidance elements."  Explaining its decision, Centene said that market growth in 22 states out of the 29 in its marketplace is not meeting expectations, and that the overall health risks in these states are much higher than what Centene had anticipated for its risk adjustment revenue calculations.  On this news, Centene's stock price fell $22.87 per share, or 40.37%, to close at $33.78 per share on July 2, 2025.  Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising.  Prior results do not guarantee similar outcomes.   CONTACT: Danielle Peyton Pomerantz LLP [email protected] 646-581-9980 ext. 7980 SOURCE Pomerantz LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News